US Broker Ratings

XOMA Royalty Corporation (XOMA): Investor Outlook on a Biotech with 86% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a..

UroGen Pharma Ltd. (URGN) Stock Analysis: Exploring a 95% Potential Upside in Biotechnology

UroGen Pharma Ltd. (NASDAQ: URGN) is making waves in the biotech industry with its innovative approach to treating urothelial and specialty cancers. With a market capitalization..

Canopy Growth Corporation (CGC) Stock Analysis: Navigating Challenges in the Cannabis Sector

Canopy Growth Corporation (NASDAQ: CGC) stands as a formidable player in the cannabis industry, with its roots deeply embedded in the Canadian market and extending to..

ServiceTitan, Inc. (TTAN) Stock Analysis: Unlocking a 45% Potential Upside Amidst Robust Revenue Growth

ServiceTitan, Inc. (TTAN) is making waves as an influential player in the technology sector, specifically within the software application industry. Based in Glendale, California, ServiceTitan offers..

Applovin Corporation (APP) Stock Analysis: Exploring a 6.27% Potential Upside with Robust Revenue Growth

AppLovin Corporation (NASDAQ: APP), a prominent player in the communication services sector, is making waves in the advertising industry with its innovative software-based platform designed to..

WeRide Inc. (WRD) Stock Analysis: A 49.77% Potential Upside in Autonomous Driving

WeRide Inc. (WRD), a prominent player in the autonomous driving sector, is capturing significant attention from investors with its impressive growth trajectory and promising market position...

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Gem with a 6.45% Potential Upside

Palvella Therapeutics, Inc. (PVLA), a trailblazer in the biopharmaceutical landscape, is capturing investor attention with its innovative approach to treating rare genetic skin diseases. Based in..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a 69.67% Potential Upside with Strategic Partnerships

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a pioneering player in the biotechnology sector, has emerged as a compelling prospect for investors with a keen eye on the..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Unveiling a Potential 115% Upside in the Biotech Sphere

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is garnering significant attention from investors seeking opportunities in the biotechnology sector, particularly those interested in companies with innovative approaches to..

NetClass Technology Inc (NTCL) Stock Analysis: A Closer Look at its Striking 52-Week Range and Market Position

NetClass Technology Inc (NTCL), a software application company based in China, has captured investor attention with its dramatic 52-week price range. Trading as low as $1.27..

Shopify Inc. (SHOP) Investor Outlook: Navigating Strong Revenue Growth and Analyst Optimism

Shopify Inc. (NYSE: SHOP), a leader in the e-commerce technology sector, continues to captivate investors with its compelling growth story and impressive market presence. With a..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Unpacking a 58.92% Potential Upside in the Biotech Sector

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands out in the biotechnology industry with promising prospects for investors, evidenced by its notable 58.92% potential upside. As a biopharmaceutical..

Alpha Teknova, Inc. (TKNO) Stock Report: Analyst Ratings Signal a Promising 85% Upside for Investors

Alpha Teknova, Inc. (NASDAQ: TKNO), a dynamic player in the healthcare sector, is generating significant buzz among investors with its promising market potential. Specializing in the..

Olema Pharmaceuticals, Inc. (OLMA): Investor Outlook Highlights 135% Potential Upside

Investors with a keen eye on the biotechnology sector might want to take a closer look at Olema Pharmaceuticals, Inc. (NASDAQ: OLMA). This San Francisco-based clinical-stage..

Viant Technology Inc. (DSP) Stock Analysis: Evaluating the 125% Upside Potential for Investors

Viant Technology Inc. (NASDAQ: DSP), a prominent player in the advertising technology sector, is drawing significant investor attention with its compelling upside potential. With a current..

Chevron Corporation (CVX) Investor Outlook: Analyzing the 11.59% Potential Upside

Chevron Corporation (NYSE: CVX) stands as a titan in the energy sector, presenting intriguing opportunities for individual investors. With a market capitalization of $306.47 billion, Chevron’s..

Kaltura, Inc. (KLTR) Stock Analysis: Unpacking Potential Upside of Over 113% with Strong Buy Ratings

Kaltura, Inc. (NASDAQ: KLTR), a key player in the software application sector, is drawing attention from investors as it exhibits significant potential for growth. With a..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring the 198.87% Potential Upside

Investors with an eye for groundbreaking biotechnology innovations should take a closer look at Entrada Therapeutics, Inc. (NASDAQ: TRDA). This Boston-based clinical-stage biopharmaceutical company is pushing..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating the Biotech Landscape with a Modest Upside

iTeos Therapeutics, Inc. (NASDAQ: ITOS) operates at the forefront of the biotechnology sector, specializing in the development of immuno-oncology therapeutics for cancer patients. Despite its promising..

Zhengye Biotechnology Holding L (ZYBT): Navigating Challenges with Free Cash Flow Strength

Zhengye Biotechnology Holding Limited (ZYBT), a niche player in the healthcare sector, is carving out its space within the drug manufacturers’ industry, focusing specifically on veterinary..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds